Delivery Order SPE2DR25D1022-SPE2DR26F1005
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,656.80 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units). This contract was competitively awarded with firm fixed pricing and no set-aside designation. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of May 14, 2025. Vemlidy is an antiviral medication used in the treatment of chronic hepatitis B,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $26,302.30 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units). Issued on May 6, 2025, with an ultimate completion date of May 7, 2025, this firm fixed-price delivery order represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in the treatment of...
- The Defense Logistics Agency awarded a delivery order valued at $20,721.48 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on October 28, 2025, with completion scheduled for October 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in the treatment of chronic...
- The Defense Logistics Agency awarded a delivery order valued at $12,079.93 to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Vemlidy 25 mg tablets (30-count unit). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of May 7, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication primarily used in the treatment of chronic hepatitis B, representing the type of...
- The Defense Logistics Agency awarded a delivery order valued at $8,288.17 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on September 19, 2025, with an ultimate completion date of September 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under a larger vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,642.26 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count unit). This firm fixed-price contract, awarded on August 29, 2025, with completion targeted for September 2, 2025, represents a non-competitive delivery order issued under a larger indefinite delivery vehicle. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an...
- The Defense Logistics Agency awarded a $13,509.57 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 19, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in the treatment of...
- The Defense Logistics Agency awarded a $12.76K delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of November 14, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in the treatment of chronic hepatitis B, representing the type of specialized...
- The Defense Logistics Agency awarded a delivery order valued at $2,919.85 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in the treatment of chronic hepatitis B, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units, with a ceiling value of $8,478.66. This is a firm fixed-price delivery order with an ultimate completion date of October 28, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral...
- SPE2DR25D1022Indefinite Delivery Contract
- SPE2DR25D1022-SPE2DR26F1005Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $44,079.30 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on November 12, 2025, with an ultimate completion date of November 13, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in the treatment of chronic hepatitis B, reflecting the federal government's ongoing pharmaceutical procurement needs for military and veteran healthcare systems. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp maintains an extensive portfolio of brand-name and generic medications across multiple therapeutic domains to support Defense Health Agency and military healthcare programs globally. The company's consistent receipt of competitively awarded delivery orders demonstrates its established capability to meet federal pharmaceutical supply requirements efficiently and at competitive pricing.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $44.1k | 11/12/25 |